Current Public Notices Published: 22 July, 2026 Published: 22 July, 2026 Published: 21 July, 2026 Published: 20 July, 2026 Published: 20 July, 2026 Published: 15 July, 2026 Published: 13 July, 2026 Published: 13 July, 2026 Published: 6 July, 2026 Published: 1 July, 2026 Published: 16 June, 2026 Current Legal Analysis More from Keller and Heckman LLP Upcoming Events Aug 11 2026 Sep 14-16 2026 Sep 17-18 2026 Sep 17-18 2026
GLP-1 medication is not for everyone, and only a licensed healthcare provider can determine whether it is appropriate
Chamberlain MC
[1] It tested once-weekly cagrilintide across a dose range and compared it with both placebo and an active comparator (liraglutide 3.0 mg)
3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies